Trial Profile
Safety, Tolerability and Pharmacokinetics of Single Dose of PB-119 in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Feb 2020
Price :
$35
*
At a glance
- Drugs Pegylated exenatide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors PegBio
- 31 Jan 2020 Results published in the European Journal of Drug Metabolism and Pharmacokinetics
- 13 Feb 2017 Status changed from active, no longer recruiting to completed.
- 09 Jun 2015 Status changed from recruiting to active, no longer recruiting as results presented at the 75th Annual Scientific Sessions of the American Diabetes Association